Genetic screening for SPINK1 (serine peptidase inhibitor, Kazal type 1), PRSS1 (cationic trypsinogen gene) and CFTR (cystic fibrosis transmembrane conductance regulator) gene mutations was performed for 12 of 30 cases with recurrent AP (40%). Here, CFTR is linked to alkaline phosphatase measurement.